The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...

Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso and Mali - as well as Haiti and Ukraine - would run out of live-saving anti-retroviral (ARV) medicines in the coming months, Dr Tedros said at a ...

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Mr Ghebreyesus said the countries which includes Haiti, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Nigeria, and Ukraine could soon run out of these life-saving medicines ...

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Experts have reported promising results from a South African HIV cure trial led by Professor Thumbi Ndung’u of the University of KwaZulu-Natal. The trial shows that 20% of participants remain off ART ...

I think what I've really wanted to do since I was a teenager was work on HIV and TB, and conditions that affected people who ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.